Inventor · disambiguated record
Joyce Taylor-Papadimitriou
Also filed as: TAYLOR-PAPADIMITRIOU JOYCE
9 granted patents·5 pending applications·208 citations·filing 1995–2018
90Inventor score
Top patents by PatentIndex Score
14 records- 0195US8440798B2Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodiesCLAUSEN HENRIK·Filed 2007·Granted May 14, 2013·67 cites·6 claims
- 0289US8912311B2Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodiesKØBENHAVNS UNI·Filed 2013·Granted Dec 16, 2014·8 cites·4 claims
- 0387US10919973B2Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodiesUNIV COPENHAGEN·Filed 2018·Granted Feb 16, 2021·2 cites·11 claims
- 0486US9359436B2Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodiesKØBENHAVNS UNI·Filed 2014·Granted Jun 7, 2016·4 cites·8 claims
- 0576US6054438ANucleic acid fragments encoding portions of the core protein of the human mammary epithelial mucinIMP CANCER RES TECH·Filed 1995·Granted Apr 25, 2000·53 cites·28 claims
- 0674US7892828B2Method of identifying a MHC class I restricted T cell responseTRANSGENE SA·Filed 2009·Granted Feb 22, 2011·3 cites·3 claims
- 0773US5683674AAntibody against human mucin core protein and method of preparing and using sameIMP CANCER RES TECH·Filed 1995·Granted Nov 4, 1997·43 cites·18 claims
- 0866US6222020B1Antigens derived from the core protein of the human mammary epithelial mucinIMP CANCER RES TECH·Filed 1995·Granted Apr 24, 2001·28 cites·32 claims
- 0963US10017576B2Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodiesUNIV COPENHAGEN·Filed 2016·Granted Jul 10, 2018·0 cites·7 claims
- 1060US2005260604A1Antigens derived from the core protein of the human mammary epithelial mucinTAYLOR-PAPADIMITRIOU JOYCE·Filed 2004·Application pending·0 cites
- 1151US2008227082A1Method of identifying a mhc class i restricted t cell responseTRANSGENE SA·Filed 2008·Application pending·0 cites
- 1250US2003211521A1Breast cancer antigenIMP CANCER RES TECH·Filed 2003·Application pending·0 cites
- 1348US2002071830A1ProbeFiled 2000·Application pending·0 cites
- 1446US2005142640A1MUC-1 derived peptidesIMP CANCER RES TECH·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →